Oxford Nanopore Technologies (private company)

See something wrong or missing? Let us know
Offices:Oxford
Business model:B2B

Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 275.13M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Oxford Nanopore Technologies

Name Criteria
Germany CatalYm
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
France InnovaFeed SAS
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Switzerland Memo Therapeutics
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 5
  • Total raised in a similar range: 10M+ USD
Spain Peptomyc
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Netherlands Salvia BioElectronics
60%
  • Similar verticals: Biotech, Electronics, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Switzerland Synendos Therapeutics
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 5
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany AMSilk
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
France Xenothera
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark Bainan Biotech
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
Top